Healthcare Contract Research Outsourcing Market, By Service Type (Safety Syringes, Regulatory services, Medical writing, Clinical data management, Others), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Healthcare Contract Research Outsourcing is conducted by pharmaceutical and medical device sectors for development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development and in the current scenario clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development is expected to propel growth of the global healthcare contract research outsourcing market over the forecast period. Furthermore, increasing number of patent expirations of leading drugs is also expected to aid in growth of the market.

Key features of the study:

• This report provides in-depth analysis of the Healthcare Contract Research Outsourcing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global Healthcare Contract Research Outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, IQVIA, Covance, Inc., Pharmaceutical Product Development Inc., Parexel International Corporation, Charles River Laboratories International Inc., Icon, Plc, Medidata Solutions, Inc., Inventiv Health, Inc. (Pharmanet Development Group Inc.), Medpace Holdings, Inc., and Piramal Life Sciences.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Healthcare Contract Research Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Healthcare Contract Research Outsourcing market

Detailed Segmentation:

• Healthcare Contract Research Outsourcing Market, By Service Type:
  • Safety Syringes
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
• Healthcare Contract Research Outsourcing Market, By End User:
  • CROs
  • Clinical Trial Laboratories
  • AMCs
• Healthcare Contract Research Outsourcing Market, By Region:
  • North America
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Service Type:
    • Clinical Trials
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory services
    • Medical writing
    • Clinical data management
    • Others
    • By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
    • By Country:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • IQVIA *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Covance, Inc.
  • Pharmaceutical Product Development Inc.
  • Parexel International Corporation
  • Charles River Laboratories International Inc.
  • Icon, Plc
  • Medidata Solutions, Inc.
  • Inventiv Health, Inc. (Pharmanet Development Group Inc.)
  • Medpace Holdings, Inc.
  • Piramal Life Sciences
• "*" marked represents similar segmentation in other categories in the respective section.